REFRACTORY THYROID GLAND MEDULLARY CARCINOMA

Clinical trials for REFRACTORY THYROID GLAND MEDULLARY CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY THYROID GLAND MEDULLARY CARCINOMA trials appear

Sign up with your email to follow new studies for REFRACTORY THYROID GLAND MEDULLARY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope pill tested for kids with tough cancers

Disease control Ongoing

This study is testing whether a pill called cabozantinib can help control rare cancers that have come back or stopped responding to other treatments in children and young adults. It includes patients with sarcomas, Wilms tumor, and other rare tumors. The drug aims to slow or stop…

Matched conditions: REFRACTORY THYROID GLAND MEDULLARY CARCINOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

REFRACTORY THYROID GLAND MEDULLARY CARCINOMA

Get alerted when new REFRACTORY THYROID GLAND MEDULLARY CARCINOMA trials appear

New hope pill tested for kids with tough cancers